Abstract:During acute lung injury, a large number of monocytes are recruited into the pulmonary tissue, which is mainly mediated by local production of monocyte chemotactic protein 1 (MCP-1). As an essential component of the lung tissues, alveolar type II epithelial cells are one of the major sources of MCP-1. Therefore, uncovering the mechanism whereby MCP-1 production is regulated in the alveolar type II cells will provide a pivotal theoretical basis for clinical intervention in acute lung injury. In the current study, we find that there is a κB binding site in the MCP-1 promoter region, and mutation of the site leads to reduced production of MCP-1 in alveolar type II epithelial cells. In contrast, overexpression of NF-κB p65 significantly increases MCP-1 expression. Furthermore, we elucidate that IKKα/β-NF-κB p65 signaling pathway and phosphorylation of serine 534 in NF-κB p65 are required for the maximal expression of MCP-1. Also, Activator protein 1 (AP-1) site in the promoter region and JNK1/2-c-Jun signaling are required for MCP-1 generation in alveolar type II epithelial cells. Moreover, a CCAAT/enhancer-binding protein (C/EBP) element is identified in the MCP-1 promoter region through the point mutation technique, and further experiments demonstrate that both C/EBPβ and C/EBPδ are involved in basic and IL-1β-mediated MCP-1 expression. Of note, specificity protein 1-Sp1 expression is not changed in alveolar type II epithelial cells incubated with IL-1β, but it still control MCP-1 production by binding to the consensus sequence in the promoter region. More importantly, we find that the results derived from the cell line-MLE-12 cells and primary cells are consistent. Taken together, our data provide insights into the molecular mechanism how MCP-1 expression in inflammatory alveolar type II epithelial cells is regulated at transcription level.

The production of monocyte chemoattractant protein-1 (MCP-1)/CCL2 in tumor microenvironments

The chemokine MCP-1 (CCL2) in the host interaction with cancer: a foe or ally?

Human Monocyte-Derived Dendritic Cells Expressing Both Chemotactic Cytokines IL-8, MCP-1, RANTES and Their Receptors, and Their Selective Migration to These Chemokines.

Involvement of Multiple Transcription Factors in Regulation of IL-β-induced MCP-1 Expression in Alveolar Type II Epithelial Cells.

Significant Reduction of T-cell Chemotaxis to MCP-1 in Patients with Primary and Metastatic Melanoma.

Monocyte Chemoattractant Protein-1 (MCP-1): An Overview

The chemokine monocyte chemoattractant protein-1/CCL2 is a promoter of breast cancer metastasis

Monocyte Chemoattractant Protein-1/CCL2 Produced by Stromal Cells Promotes Lung Metastasis of 4T1 Murine Breast Cancer Cells

MCP-1: Function, regulation, and involvement in disease

Generation, characterization and biological activity of CCL2 (MCP-1/JE) and CCL12 (MCP-5) specific antibodies

The CCR2/MCP-1 Chemokine Pathway and Lung Adenocarcinoma

T Cell Chemotactic Response in Patients with Primary and Metastatic Malignant Melanoma

More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis

CCL2: An Important Mediator Between Tumor Cells and Host Cells in Tumor Microenvironment

The Expression of Chemokine MCP-1 in Colorectal Carcinoma and Its Relationship to the Infiltration of Macrophage

High-motility pro-tumorigenic monocytes drive macrophage enrichment in the tumor microenvironment

Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Drives Activation of Bone Remodelling and Skeletal Metastasis

How Are MCPIP1 and Cytokines Mutually Regulated in Cancer-Related Immunity?

Regulatory Roles of Osteopontin in Production of Monocyte-Origin MCP-1.

Monocyte Chemotactic Protein-1 Promotes the Proliferation and Invasion of Osteosarcoma Cells and Upregulates the Expression of Akt

Expression of Chemokine MCP-1 in Colorectal Carcinoma and its Relationship with the Infiltration of Immunocyte